Although tyrosine phosphorylation of extracellular proteins has been reported to occur extensively in vivo, no secreted protein tyrosine kinase has been identified. As a result, investigation of the potential role of extracellular tyrosine phosphorylation in physiological and pathological tissue regulation has not been possible. Here, we show that VLK, a putative protein kinase previously shown to be essential in embryonic development, is a secreted protein kinase, with preference for tyrosine, that phosphorylates a broad range of secreted and ER-resident substrate proteins. We find that VLK is rapidly and quantitatively secreted from platelets in response to stimuli and can tyrosine phosphorylate coreleased proteins utilizing endogenous as well as exogenous ATP sources. We propose that discovery of VLK activity provides an explanation for the extensive and conserved pattern of extracellular tyrosine phosphophorylation seen in vivo, and extends the importance of regulated tyrosine phosphorylation into the extracellular environment.
INTRODUCTION
An extraordinary and little-recognized observation has emerged from analysis of the mammalian phosphoproteome: a substantial portion of secreted or extracellular proteins have been reported to contain phosphotyrosine (Hornbeck et al., 2012) , but, to date, no secreted tyrosine kinase has been identified. Tyrosine phosphorylation of a wide range of extracellular matrix (ECM) and pericellular proteins has been reported in high-throughput liquid chromatography tandem mass spectrometry (LC MS/ MS) analysis of tissue samples of both healthy and diseased tissues (Hornbeck et al., 2012) . In many instances, tyrosine phosphorylation at these sites has been reported in multiple independent studies using material from both cultured cell and primary tissue samples (Ballif et al., 2008; Hornbeck et al., 2012) . In light of the emerging importance of ECM as a dynamically regulated microenvironment with a fundamental role (Hynes and Naba, 2012; Lu et al., 2011) in the control of cell differentiation, survival, and function, tyrosine phosphorylation of ECM proteins represents a potential major new mechanism of tissue regulation.
Phosphorylation of the secreted acidic milk protein casein has been known for over a century (Tagliabracci et al., 2013; Yalak and Vogel, 2012) , but only in 2012 was the kinase responsible for the serine phosphorylation of casein and other acidic secreted proteins identified (Tagliabracci et al., 2012) . Fam20C, a Golgi localized protein kinase, is a serine kinase that phosphorylates both casein and other highly acidic proteins such as osteopontin and members of the small integrin-binding ligand, N-linked glycoproteins (SIBLING) family at the target motif SerXGlu (Tagliabracci et al., 2012) . Phosphorylation by Fam20C in the secretory pathway is robust and essential for proper biomineralization of bone. The substrate specificity of FAM20C indicates, however, that it is not likely to account for the tyrosine phosphorylation of the secreted proteins described above. The discovery of FAM20C highlighted, however, that the mammalian secretory kinome may be largely unexplored, with an unknown number of secreted protein kinases yet to be identified (Tagliabracci et al., 2013; Yalak and Vogel, 2012) .
In many ECM and matricellular proteins, tyrosine phosphorylations occur at structurally conserved positions in otherwise distantly related proteins (Hornbeck et al., 2012) , suggesting a conserved regulatory roles for these modifications The hemopexin domain of matrix metalloproteinases (MMPs) provides a clear example of this phenomenon. Seven different MMP family members have been reported to be tyrosine phosphorylated within their C-terminal hemopexin domains ( Figure 1A ) (Guo et al., 2008; Hornbeck et al., 2012; Raijmakers et al., 2010; Rikova et al., 2007) . In each case, the phosphotyrosine is found at a conserved b-bulge in blade 2 of the hemopexin 4-blade propeller structure ( Figure 1B ). Strikingly, phosphorylation at an identical position is also seen in lubricin (Rinschen et al., 2010) and hemopexin (Rinschen et al., 2010) , proteins which contain the hemopexin domain structure but which are only distantly related to MMPs ( Figure 1B ). While the structural conservation of these tyrosine phosphorylations is intriguing, in the absence of any known secreted tyrosine kinases there has been no way to study the regulation or role of this novel class of tyrosine phosphorylations.
To understand the regulation and significance of the tyrosine phosphorylation of secreted proteins, we re-examined the existing kinome and associated literature for unrecognized secreted protein kinases. The putative protein kinase VLK/PKDCC (hereafter VLK) emerged from this search as a promising candidate for a secreted tyrosine kinase. The Vlk gene (also known as sgk493, adtk1, and AW548124) was cloned as a putative protein kinase expressed in differentiating embryonic stem cells (Gon-ç alves et al., 2011; Imuta et al., 2009; Kinoshita et al., 2009) . Vlk À/À mice die within one day of birth, with severe defects in morphogenesis in multiple tissues, indicating that Vlk is essential for patterning at organogenesis stages (Gonç alves et al., 2011; Imuta et al., 2009; Kinoshita et al., 2009; Probst et al., 2013) . Vlk encodes a protein with clear homology to protein kinases ( Figures 2A, and S2 ), but lacking recognizable homology in kinase subdomains V, IX, X, and X1 (Hanks, 2003; Kinoshita et al., 2009) , and by primary sequence is not distinguishable as a member of the major serine-threonine, tyrosine, or dual specificity subsets of intracellular protein kinases ( Figure S2A ). Strikingly, VLK contains a predicted hydrophobic sequence near the N terminus that we find to be recognized as a signal sequence by multiple signal sequence prediction algorithms (Horton et al., 2007; Petersen et al., 2011) (Figure 2A ). We demonstrate here that VLK is a secreted protein kinase with preference for tyrosine residues and that it phosphorylates secreted proteins at sites identical to many of those previously reported to occur in vivo. Expression of VLK results in the tyrosine phosphorylation of both secreted and ER/Golgi resident proteins, and these phosphorylations are dependent on the signal peptide as well as the active kinase domain of VLK. VLK is constitutively secreted by mammalian cell lines and is highly expressed in human platelets, localized to secretory granules, and quantitatively released following platelet degranulation. Furthermore, tyrosine phosphorylation of proteins secreted from stimulated platelets is VLK dependent and can be supported by endogenous secreted ATP. These observations identify VLK as the first secreted protein tyrosine kinase, which can act not only in the secretory pathway but also following its regulated release outside the cell.
RESULTS

VLK Localizes to the Secretory Pathway and Is Glycosylated
To test localization of VLK to the lumenal compartment of the secretory pathway, we expressed VLK in 293T cells and treated detergent-free cell lysates with proteinase K (PK) alone or in combination with NP40. Proteins localizing to the cytoplasm, like GFP, are degraded by PK treatment, while proteins localized to the lumenal side of the ER or Golgi are protected by the lumenal membrane in the absence of detergent (Brown et al., 1987) . VLK was not degraded by PK alone, but was completely degraded with the addition of NP40 ( Figure 2B ), indicating that VLK localizes to a membrane protected subcellular compartment. To test if the predicted N-terminal signal peptide in VLK is responsible for its localization, we generated a tagged construct lacking the first 23 amino acids (VLK ÀSP ). VLK ÀSP was completely degraded following PK treatment in the absence of detergent ( Figure 2C ), demonstrating signal-peptide dependent localization of VLK to the secretory pathway. Furthermore, full-length VLK, but not VLK ÀSP was found in the conditioned media (CM) of transfected cells ( Figure 2D ) confirming the requirement of the VLK signal peptide for secretion. Moreover VLK, but not VLK ÀSP , is strongly phosphorylated on tyrosine ( Figure 2D ).
VLK contains five potential sites for N-linked glycosylation (AsnXSer/Thr). To test if VLK is glycosylated in the secretory (Jozic et al., 2005) , MMP13 (MMDB ID: 57090) (Gomis-Rü th et al., 1996) and hemopexin (MMDB ID:56395) (Faber et al., 1995) . Yellow arrow indicates reported site of tyrosine phosphorylation (Tyr360 in hMMP1, Tyr366 in hMMP13, Tyr341 in hHPX) (Hornbeck et al., 2012; Raijmakers et al., 2010) . See also Figure S1 . pathway, we treated lysates of cells expressing either VLK or VLK ÀSP with PNGase F, which removes N-linked oligosaccharides. A shift in gel migration was observed for VLK, indicating the presence of N-linked glycosylations, whereas VLK ÀSP was unaffected ( Figure 2E ).
Endogenous VLK Is Secreted into CM
We next examined the localization of endogenous VLK to the secretory pathway. Preliminary screening established detection of endogenous VLK in several established lines, with high expression seen in HepG2 liver hepatoma cells. As for ectopically expressed VLK, endogenous VLK in HepG2 cells was not degraded by PK treatment in the absence of NP40 ( Figure 2F ). Progressive Figure S2 . and quantitative accumulation of endogenous VLK was detected in the CM of HepG2 cells ( Figure 2G ). VLK secretion was abrogated by the addition of the ER/ Golgi protein transport inhibitor brefeldin A, with a corresponding increase in cellassociated VLK ( Figure 2G ). Secreted VLK is found in the supernatant of HepG2 conditioned medium centrifuged at 100,000 3 g, indicating that it is not associated with microvesicular or exosome particles (Figure 2H ). The specificity of antibody detection of endogenous VLK was confirmed by lentiviral-mediated knock-down of Vlk with two independent shRNA constructs ( Figure 2I ). These data establish that endogenous VLK is quantitatively localized to the secretory pathway, and is constitutively released from cultured cells.
VLK Phosphorylates Substrates following Stimulated Release from Platelets
To explore the possibility that VLK secretion is physiologically regulated, we examined the ligand stimulated degranulation of human platelets. VLK is abundantly expressed in platelets ( Figures 3A and S3A) . Stimulation of platelet degranulation with either the thrombin receptor agonist thrombin receptor activating peptide (TRAP) (Ahn et al., 1997) or phorbol-12-myristate-13-acetate (PMA) (Rozenvayn and Flaumenhaft, 2003) , led to the rapid release of VLK into the cell supernatant, concomitant with the release of the alpha granule markers von Willebrand Factor (vWF) protein and thrombospondin (TSP1) (Harrison and Cramer, 1993) (Figure 3A , 3B). Notably, TRAP stimulation resulted in a dramatic decrease in the amount of cell-associated VLK concomitant with the increase of VLK in the cell supernatant, indicating that the stimulus-dependent release of VLK is nearly complete.
Anti-pTyr immunoblotting of unstimulated versus TRAP stimulated platelets revealed that several tyrosine phosphorylated proteins are detectable in the releasate. The most prominent of these secreted phosphotyrosine bands comigrates with VLK, suggesting that secreted VLK is tyrosine phosphorylated endogenously in platelets ( Figure 3A ). Addition of supplemental ATP to cell-free supernatant released from TRAP or PMA stimu- lated platelets resulted in an increase in tyrosine phosphorylation of releasate proteins, indicating that tyrosine phosphorylation can occur in the extracellular environment following regulated tyrosine kinase secretion ( Figure 3A ). Depletion of secreted VLK with an anti-VLK antibody markedly decreased tyrosine phosphorylation following ATP addition, establishing that secreted VLK phosphorylates substrates in the extracellular environment ( Figure 3B ). While VLK dependent tyrosine phosphorylation was strongly stimulated by ectopic ATP addition, significant tyrosine phosphorylation of identical bands was seen in the absence of ATP addition ( Figure 3B ). Since platelets secrete ATP from dense granules concomitantly with protein release from alpha granules (McNicol and Israels, 1999) , we examined the effect of depletion of endogenous coreleased ATP with added apyrase on tyrosine phosphorylation. Apyrase addition dramatically reduced phosphorylation of a set of tyrosine phosphoprotein bands similar to those reduced by VLK depletion ( Figure 3B , marked with asterisks), indicating that endogenous ATP can support the tyrosine phosphorylation of protein secreted from platelets subsequent to degranulation ( Figure 3B ).
Immunolocalization of VLK in unstimulated platelets by confocal microscopy shows a punctate pattern consistent with localization to alpha granules ( Figure 3C , Figure S3B ), and electron microscopy confirms VLK localization to these structures ( Figure 3D ). Immunohistochemical staining of mouse megakaryocytes, which give rise to mature platelets (Italiano et al., 1999) , showed a punctate distribution similar to that seen in mature human platelets ( Figure S3D ), suggesting that VLK is likely synthesized during megakaryocyte development and distributed to nascent platelets.
VLK Phosphorylates a Variety of Extracellular Proteins
Existing phosphoproteomic data sets pointed to a wide range of secreted proteins that are phosphorylated on tyrosine in vivo. We used these data as a guide to the testing of candidate substrates for VLK phosphorylation, with a focus on phosphorylations that had been reported at sites conserved across broad sets of related proteins. MMPs were strong candidates in this regard, due to the numerous reports of tyrosine phosphorylation in vivo of the hemopexin domain in a subset of MMPs ( Figure 1A ). Coexpression of VLK with hMMP1, hMMP13, hMMP14, hMMP19 and bMMP27 in each case resulted in tyrosine phosphorylation of the MMP ( Figure 4A and Figure S4A ). Additional substrates, structurally unrelated to MMPs, but suggested as potential substrates by reports of tyrosine phosphorylation in vivo (laminin A1, FUT8, TNFSF10) (Hornbeck et al., 2012) , were also phosphorylated when coexpressed with VLK ( Figure 4A and Figure S4A ), suggesting that VLK substrates are not limited to a single class of proteins or structural motifs. Phosphorylation of coexpressed proteins was not seen with VLK mutated at a key residue (Lys166) in the predicted ATP binding site (VLK KM ) (Kinoshita et al., 2009) , or with VLK ÀSP ( Figures   4A and 4B ). In addition to its predicted kinase domain and signal peptide, a distinctive feature of VLK, conserved across mammalian orthologs, is a proline glycine (PG) rich domain N-terminal to the start of the kinase domain ( Figure 2A ). Deletion of this conserved PG rich region (VLK DPG ) also eliminates the phosphorylation of coexpressed substrates ( Figure S4B ), as well as of VLK DPG itself ( Figure S4C ). To examine whether endogenous, as well as ectopically expressed VLK, could support tyrosine phosphorylation of a secreted protein, we tested the effect of downregulation of endogenous VLK on MMP13 phosphorylation. shRNA-mediated downregulation of VLK reduced expression of endogenous VLK in 293T cells, with a concomitant reduction in the tyrosine phosphorylation of tagged MMP13 in the CM of transfected cells ( Figure 4C ). MMP1 has been reported to be tyrosine phosphorylated in leukocytes in vivo on tyrosine Y360 (Raijmakers et al., 2010) . Examination of material released from platelets established that endogenous MMP1 is tyrosine phosphorylated in platelets, and is released in response to stimulation by TRAP ( Figure 4D ). To determine whether VLK can phosphorylate MMP1 on the same site reported in vivo, we performed LC-MS/MS on a protein sample of MMP1 that had been coexpressed with VLK, and found that Y360 is the major tyrosine phosphorylated site in MMP1 under these conditions ( Figure S4D ) indicating that the principle site of MMP1 phosphorylation by VLK is identical to that reported in vivo. Expression of MMP1 in which Y360 was mutated to phenylalanine showed only partially reduced tyrosine phosphorylation in the presence of VLK, however, indicating that additional sites are tyrosine phosphorylated ( Figure S4E ), apparently below the detection limit of tandem mass spectrometry. LC-MS/ MS analysis also identified phosphorylated serine (S57) and threonine (T274) residues in MMP1 ( Figure S4D) ; raising the possibility that VLK modifies serine and threonine as well as tyrosine residues in MMP1.
VLK Kinase Activity Is Necessary for Its Release from the Cell Wild-type VLK accumulates in the CM of cells in which it is ectopically expressed. In striking contrast, very little VLK KM is secreted into CM ( Figure 4E ), suggesting that VLK kinase activity is necessary for its secretion. To confirm the importance of the kinase domain in VLK secretion, we generated two additional VLK mutants in which highly conserved residues in the predicted kinase domain were modified (VLK Figure 4E ). VLK has been previously reported to be phosphorylated at Y148 (Kinoshita et al., 2009 ); mutation of this site to phenylalanine does not alter VLK secretion, indicating that autophosphorylation at this site is not involved in the control of VLK progression through the secretory pathway ( Figure 4E ). Mutation of Y148 also had no effect on the ability of VLK to phosphorylate coexpressed substrates ( Figure S4I , upper). Tyrosine phosphorylation of VLK was still seen in the Y148F mutant, but not in the kinase dead VLK constructs, suggesting the existence of additional VLK autophosphorylation sites (Figures S4F and S4I, lower) . These data indicate that VLK kinase activity is important for its release from the cell, but whether this is due to autophosphorylation on uncharacterized sites or to phosphorylation of other substrates in the secretory pathway is not clear.
VLK Phosphorylates Endogenous Proteins in the Secretory Pathway
To define the spectrum of VLK-dependent phosphorylation of endogenous proteins, we generated K4 fibroblasts stably expressing either VLK or VLK KM . Expression of wild-type VLK, but not VLK KM , resulted in a dramatic increase in total cellular tyrosine phosphoprotein ( Figure 5A ). Because VLK diverges strongly from cytosolic tyrosine protein kinases in its kinase domain, we expected that VLK kinase activity would not be reduced by inhibitors of cytosolic tyrosine kinases. Treatment of cells with the broad spectrum tyrosine kinase inhibitor dasatinib (Shah et al., 2004 ) strongly reduced tyrosine phosphoprotein bands shared among GFP K4, VLK K4, and VLK KM K4 cells, but had no effect on bands unique to VLK K4 cells ( Figure 5A ). Tyrosine phosphorylation in the CM of K4 cells was exclusively detected following VLK but not VLK KM overexpression ( Figure 5B) , and the accumulation of these proteins in CM was abrogated by treatment with brefeldin A ( Figure S5C ). VLK-dependent phosphorylations were, like VLK itself, protected from PK treatment in detergent-free lysates ( Figure S5A ). No changes in threonine or serine phosphorylations in K4 cell lysates were seen following VLK overexpression ( Figure S5B ) and no serine or threonine phosphorylations at all could be detected in the CM of K4 cells ( Figure S5C ). The predominant detectable change in overall protein phosphorylation associated with VLK expression therefore appears to be phosphotyrosine.
To identify endogenous substrates for VLK, we did antiphosphotyrosine (anti-pTyr) immunoprecipitation of tryptic digests of total cell protein and total CM from VLK expressing cells, followed by identification of phosphopeptides by LC-MS/MS (Breitkopf and Asara, 2012) . One hundred and forty distinct tyrosine phosphopeptides were identified, of which 48 tyrosine (C) MMP13 was overexpressed in 293T cells stably transduced with either a scrambled shRNA or an shRNA targeting VLK (#5). Tyrosine phosphorylation was examined in CM following MMP13 immunoprecipitation. VLK expression was determined in cell lysates (Lys.) (D) Freshly isolated human platelets were treated with 0.5 mM TRAP for 15 min. After centrifugation to remove cells, protein expression and tyrosine phosphorylation were determined in pellets and supernatants.
(E) Detergent-free lysates of 293T cells expressing the indicated VLK constructs were treated with PK alone or in combination with NP40. See also Figure S4 .
phosphopeptides mapped either to proteins containing canonical signal peptides or to the extracellular domains of transmembrane proteins (Table 1 and Data S1). In addition, several tyrosine phosphopeptides were exclusively detected in CM (Table 1) . Of the 48 secretory/extracellular tyrosine phosphopeptides identified, 11 have been identified in biosamples from in vivo tissue (Hornbeck et al., 2012) . The most frequently detected phosphopeptide in VLK expressing K4 cells occurred at Tyr66 in ERP29, an ER chaperone that is the mammalian homolog of the Drosophila developmental mutation windbeutel. Tyr66, conserved in windbeutel, is essential for chaperone function (Barnewitz et al., 2004) , and has been found to be phosphorylated both in vivo and in a wide range of cell lines in 366 separate MS-MS analyses (Bai et al., 2012; Ding et al., 2011; Gu et al., 2011; Guo et al., 2008; Hornbeck et al., 2012; Rikova et al., 2007) . These observations indicate that the tyrosine phosphorylation of specific sites in secretory pathway proteins occurs in vivo under endogenous conditions of VLK expression as well as in the presence of ectopic VLK. Comparison of tyrosine phosphorylation in cells expressing wild-type VLK or VLK KM using SILAC analysis established that only proteins in the secretory pathway, and not cytoplasmic proteins, showed increased tyrosine phosphorylation in the presence of wild-type VLK, confirming that VLK is likely to act specifically on proteins in the secretory pathway (Table S1 ). To further confirm that the tyrosine phosphorylation in secretory pathway proteins was VLK dependent, we performed immunoblot analysis for several candidate VLK substrates on phospho-tyrosine immunoprecipitation of lysates from K4 VLK or K4 VLK KM cells ( Figure S5D ). To confirm that tyrosine kinase activity is intrinsic to VLK, and is inactivated by mutation of Lys166, wild-type and mutant proteins were expressed and purified in a baculoviral expression system. Wild-type, but not mutant, VLK protein, phosphorylated both a peptide derived from the hemopexin domain of MMP1 (HpxPeptide) or a peptide designed as an optimal substrate based on tyrosine phosphopeptides identified in VLK expressing cells (Ypeptide) ( Figure 6A ). Wild-type, but not mutant, VLK protein also directly phosphorylated purified ERP29 protein, and showed dramatically reduced phosphorylation of mutant ERP29 lacking the sites of tyrosine phosphorylation identified in VLK expressing cells and in vivo (Tyr64/Tyr66) ( Figure 6B ). Kinase activity was optimal in the presence of a combination of Mg 2+ and Ca 2+ , and was only weakly supported by Mn 2+ (Figure S6 ). The specific activity of VLK purified from the baculoviral system, $0.2 nmol/min/mg, was 10-to 100-fold lower than activities typically observed for cytoplasmic tyrosine kinases. VLK phosphorylated peptides in which the tyrosine residue was replaced with serine (Speptide) or threonine (Tpeptide) with reduced efficiency ( Figure 6A ). These data establish that purified VLK has intrinsic kinase activity with a preference for tyrosine, and can phosphorylate ERP29 on the same tyrosines shown to be phosphorylated in VLK-expressing cells and in vivo.
DISCUSSION
There Is a Broad Range of Potential Substrates for VLK In Vitro and In Vivo Examination of an unbiased set of secreted and lumenal tyrosine phosphoproteins from VLK expressing cells reveals a broad set of VLK substrates, many of which correspond to tyrosine phosphorylations in secreted proteins seen in vivo (Table 1) . While our initial studies focused on the MMPs as candidate substrates, the broader set of substrates we find in VLK-expressing fibroblasts do not share evident structural features with MMP hemopexin domains or with one another. They also do not share any clear local motif surrounding the phosphorylation site, in contrast to the secreted serine kinase FAM20C, which targets the local motif SerXGlu (Tagliabracci et al., 2012) . The basis for substrate recognition by the VLK kinase activity therefore remains puzzling. Phosphorylation by VLK may depend on some combination of surface exposure of tyrosine, juxtaposition of specific amino acids in the tertiary structure around the phosphorylation site, and/or association of VLK with multiple targeting subunits that direct the kinase activity to distinct classes of substrates. Ectopic expression of VLK in fibroblasts substantially alters total cellular protein tyrosine phosphorylation ( Figure 5A ), establishing that VLK-dependent phosphorylation in cells is quantitatively similar to the sum of activities of endogenous cytosolic tyrosine kinases. The low activity of purified VLK protein therefore seems paradoxical and may reflect inefficient folding or disulfide bond formation in the ER in the baculovirus/S9 system, Total tyrosine phosphopeptides were isolated by anti-pTyr immunoprecipitation of tryptic digests of cell lysates or CM and analyzed by LC-MS/MS. One hundred and forty unique phosphopeptides were identified, of which 48 (listed here) were mapped to proteins with canonical signal peptides, or extracellular domains of transmembrane proteins, as annotated in UniprotKB. Peptides identified exclusively in conditioned medium are shaded in bold. Tyrosine phosphorylation sites reported to occur in vivo in Phosphosite are marked with a ''Y,'' in parentheses the number of separate studies is shown. ''TC'' designates sites that were detected in only in tissue culture cell lines. See also Table S1 and Data S1.
lack of a lumenal modifying enzyme required for optimal activity in this system, or lack of an important mammalian modifying subunit or cofactor. Elimination of the VLK signal peptide eliminates VLK autophosphorylation (Figures 2 and 4) , suggesting that lumenal chaperones or other lumenal proteins are essential for proper folding/activity of the secreted kinase domain. Phosphorylation by VLK may also require secondary or tertiary structural features of the substrate that are not recapitulated by the test substrates used here. A third possibility is that lumenal tyrosine phosphatase activity may be much lower than cytosolic tyrosine phosphatase activity, allowing a low turnover lumenal tyrosine kinase to sustain significant lumenal/secreted tyrosine phosphorylation. Defining the mechanism by which VLK activity and substrate recognition are regulated will be an important area for further investigation.
Relationship between VLK Substrates and Phenotype
Loss of VLK results in perinatal lethality with defects in skeletal, lung, and craniofacial development (Imuta et al., 2009; Kinoshita et al., 2009; Melvin et al., 2013; Probst et al., 2013) . During embryogenesis, VLK is expressed strongly in mesenchymal condensations in bone, lung, and elsewhere and is broadly expressed at lower levels in the adult (Kinoshita et al., 2009 ) (Imuta et al., 2009 ). In human genome-wide association studies (GWAS), VLK has been correlated with variations in bone density, consistent with a role in skeletal development or homeostasis (Hsu and Kiel, 2012) . At the cellular level, the best characterized defect in VLK null animals is in the differentiation of chondrocytes in long bones (Imuta et al., 2009; Kinoshita et al., 2009; Probst et al., 2013) . Our studies identify a variety of VLK substrates with established roles in skeletal development, including type I collagen (Prockop, 1985) , MMP13 (Stickens et al., 2004) , MIA3 (an essential collagen chaperone) (Wilson et al., 2011) , and MESD (a chaperone for the wnt receptor LRP5/ 6) (Hsieh et al., 2003; Zhang et al., 2004) . At this point, it is not possible to assess whether the VLK null phenotype reflects a major functional alteration in one or two key substrates, or more subtle changes in a broad set of functionally interacting substrates that collectively impact chondrocyte differentiation.
Our work also suggests a role for VLK in platelet function. VLK protein is present in greater relative abundance in platelets than in any other cell type we have examined, and is quantitatively released following stimulation of platelet degranulation. Proteins secreted following platelet degranulation regulate thrombosis, angiogenesis, inflammation, and tissue remodeling during wound healing and tumorigenesis (Blair and Flaumenhaft, 2009; Harrison and Cramer, 1993) . MMP1, which we have found to be directly phosphorylated on tyrosine by VLK, is also cosecreted from platelets with VLK, and is tyrosine phosphorylated in this releasate ( Figure 4D ) as well as in vivo (Raijmakers et al., 2010) . MMP1 has a role both in platelet activation itself (Santos-Martínez et al., 2008) and in tissue remodeling associated with wound healing (Raffetto and Khalil, 2008) . In addition, a variety of secreted proteins involved in the regulation of thrombosis are tyrosine phosphorylated in vivo (Hornbeck et al., 2012) , suggesting a potential role for secreted tyrosine kinase activity in the control of thrombosis.
Potential Functions of VLK Phosphorylation Sites
The number and diversity of VLK phosphorylation sites that we have identified makes it difficult to generalize regarding the potential function of these phosphorylations. In a number of instances, however, existing structural or functional information points to specific roles for some of the tyrosine phosphorylations we have found. The tyrosine phosphorylation in osteopontin, for example, occurs in the middle of the integrin alpha9beta1 binding sequence SVVY*GLR and the addition of a charged phosphate in the middle of this short recognition site would be strongly predicted to modulate integrin binding (Yokasaki and Sheppard, 2000) . The phosphorylation site in Type I collagen occurs 2 amino acids N-terminal to the C-propeptide maturation site (Kessler et al., 1996) , pointing to a role for tyrosine phosphorylation in collagen maturation.
Resident ER chaperones comprise a significant portion of VLK substrates, suggesting that at least one function of VLK is to modulate the secretory pathway. In the cases of the ER chaperones MESD and ERP29, the tyrosines that we have found to be phosphorylated are each established to have an essential role in the interaction of these chaperones with specific substrates (Barak et al., 2009; Chen et al., 2010; Chen et al., 2011) , also indicating a role for phosphorylation in the modulation of core protein function. Kinoshita et al. previously reported that ectopic VLK expression reduced the overall rate of VSVG progression through the secretory pathway (Kinoshita et al., 2009 ), but this effect was seen equally with expression of WT VLK and VLK KM , the latter of which we have found to be inactive as a protein kinase. This general effect on secretion therefore appears not to be associated with the catalytic activity of VLK, but whether VLK selectively modifies chaperone function by phosphorylation remains an open question. Ectopically expressed VLK has been reported to colocalize with Golgi markers in immunohistochemical analysis (Kinoshita et al., 2009) . The abundant phosphorylation of ER resident proteins we find in VLK expressing cells indicates that VLK is either present and active in the ER or that it phosphorylates these proteins in the Golgi during cycling between these compartments. Interestingly, we find that VLK mutants that lack kinase activity are no longer efficiently secreted from the cell, suggesting that the catalytic activity of VLK modulates its own progression through the secretory pathway.
Does VLK Function in the Secretory Pathway, or Outside the Cell, or Both? The characterization of FAM20C as an active serine kinase in the Golgi apparatus provides a clear precedent that ATP dependent protein phosphorylation can take place in the secretory apparatus (Tagliabracci et al., 2012; Yalak and Vogel, 2012) . Under the conditions of our experiments in fibroblasts, there is no significant source of ATP outside the cell, and therefore the VLK phosphorylations we observe in these cells are likely to take place within the secretory pathway. In platelets, however, dense granules provide an abundant local source of extracellular ATP following stimulation of secretion (McNicol and Israels, 1999) . We find that this endogenous ATP pool can sustain de novo tyrosine phosphorylation of secreted proteins in platelet releasate ( Figure 3B ) indicating that secreted tyrosine kinase activity can be supported by an endogenous source of extracellular ATP. The concentration of ATP in platelet dense granules is estimated to be 0.1-1 M (Gordon, 1986; McNicol and Israels, 1999) , and the local concentration of ATP following degranulation in thromboses has been estimated to be well within the range required for protein kinase activity (Gordon, 1986) . The corelease of VLK and ATP from platelets therefore provides the first plausible example of de novo tyrosine phosphorylation in the extracellular environment. ATP release from a broad range of both excitable and nonexcitable cell types is also well known, and has been proposed to support extracellular kinase activity (Praetorius and Leipziger, 2009; Yalak and Vogel, 2012) . Extracellular ATP has also been reported to be elevated in the tumor microenvironment (Pellegatti et al., 2008) and to have a variety of protumorigenic properties (Braganhol et al., 2013; Stagg and Smyth, 2010) . Tyrosine phosphorylation on ER-resident proteins such as ERP29 in vitro and in vivo indicates that endogenous VLK has significant activity intracellularly in the secretory pathway, but the regulated secretion of active VLK from platelets points strongly to a significant role for VLK in the extracellular environment as well.
Patterns of Secreted Tyrosine Phosphorylation In Vivo
A striking feature of tyrosine phosphorylation of secreted proteins in vivo is the conservation of phosphorylation sites in specific structural motifs in distantly related proteins. In addition to the hemopexin domains noted in the Introduction, immunoglobulin (IG) domains, fibronectin (FN3) domains, and VWA domains, are phosphorylated on tyrosine in multiple proteins, and these phosphorylations can be localized to conserved structural features within the domain ( Figure S1 ). Conserved tyrosine phosphorylation of modular domains in ECM proteins (Hynes and Naba, 2012) in vivo can be found in many additional domain classes (e.g., CUB, TSP1, FN1, and FN2), but in these cases insufficient structural information is available to place the phosphorylations relative to a common structural feature. While VLK may be responsible for many of these phosphorylations, additional secreted kinases may be responsible for the full spectrum of secreted tyrosine phosphorylations reported in vivo. Bioinformatic work has identified several other putative secreted proteins with significant similarity to VLK, suggesting that the secreted protein kinome may still be far from complete (Dudkiewicz et al., 2013; Tagliabracci et al., 2013) .
CONCLUSION
Our work places VLK with FAM20C as members of a new class of regulator of extracellular proteins, the secreted protein kinases. Fam20C and VLK are evolutionarily more distant from one another than they are from canonical cytoplasmic kinases, suggesting that the evolution of multiple secreted kinases occurred as independent events rather than divergence from a primordial secreted kinase. The breadth and conservation of extracellular structural and regulatory proteins that are found to be phosphorylated in vivo makes it likely that defining the physiological roles of secreted protein kinases will have a major impact on our understanding of both normal tissue homeostasis and disease pathogenesis.
EXPERIMENTAL PROCEDURES
Proteinase K Protection Assay Cells were incubated in an isotonic extraction buffer and lysed using a Dounce homogenizer and incubated in the presence of proteinase K alone or in combination with 1% NP40. Proteolysis was terminated with PMSF and samples analyzed by western blot.
Analysis of Ectopically Expressed VLK with Candidate Substrates
293T cells were transfected with cDNAs encoding wild-type or mutant VLK constructs with or without cotransfection of candidate epitope tagged substrates. After 24-48 hr cell lysates or CM were immunoprecipitated with antitag antibody and analyzed for total expression or tyrosine phosphorylation by western blot.
Microscopy
Platelets were fixed in 4% formaldehyde and centrifuged onto poly-L-lysine (1 mg/ml)-coated coverslides, and analyzed for immunofluorescence with anti-VLK antibody by scanning confocal microscopy as described in Extended Experimental Procedures. Rapid-freeze immunogold electron microscopy of washed human platelets was performed as previously described (Italiano et al., 1999) .
Platelet Release Assay
Whole blood was collected and platelets were isolated as previously described (Thon et al., 2012) . Platelets were treated with 0.2 mM phorbol-12-myristate-13-acetate (PMA) or 0.5 mM thrombin-receptor activating peptide (TRAP) to induce degranulation. After 4 min of treatment, cells were removed by centrifugation, and the supernatant (releasate) was treated with ATP, apyrase, or anti-VLK antibody as described in the legend to Figure 3 .
Kinase Assays
Mus musculus VLK (amino acids 55-492) was cloned into a modified pl-secSUMOstar vector (LifeSensors) containing a tobacco etch virus (TEV) cleavage site, and recombinant protein purified from CM as described in Extended Experimental Procedures. For peptide kinase assays, 0.1 mg of purified recombinant protein was incubated with 5 mM 33 [P]-g-ATP, 5 mM MgCl 2 , 0.5 mM CaCl 2 , 50 mM Tris pH 7.5, and 1 mM biotinylated peptide, and then biotinylated peptide was collected on streptavidin agarose and counted in a liquid scintillation counter. For ERP29 phosphorylation assays, purified wild-type or mutant ERP29 was assayed as substrate for phosphorylation by purified VLK as described above, and analyzed by Laemmli gel electrophoresis and autoradiography.
Mass Spectrometry K4 fibroblasts stably expressing retrovirally transduced wild-type VLK or VLK KM were lysed with urea lysis buffer, digested with trypsin, and tyrosine phosphopeptides isolated by immunoprecipitation and analyzed as described in Extended Experimental Procedures. CM from transduced fibroblasts was precipitated with TCA and then solubilized and analyzed as for cell lysates. 
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